Corbin Therapeutics' Seed VC Round

Corbin Therapeutics raised a round of funding on January 11, 2017. Investors include AmorChem.

Corbin Therapeutics is a biotech company using a drug discovery platform to identify and develop novel USP15 inhibitors for treatment of various inflammation diseases, such as multiple sclerosis. This…

Articles about Corbin Therapeutics' Seed VC Round: